Hemodynamic changes in pregnancies with impaired fetal growth: A systematic review and meta-analysis

Britt M J G Kempener1, Laura M Jorissen1,2, Eva G Mulder2

  • 1Department of Obstetrics and Gynecology, Maastricht University Medical Centre, Maastricht, the Netherlands.

Insights

Pregnancies with impaired fetal growth show higher total peripheral vascular resistance (TPVR) and lower cardiac output (CO) from the second trimester. Severe cases, especially with placental issues, have the most pronounced hemodynamic changes.

Area of Science:

  • Cardiovascular Physiology
  • Reproductive Medicine
  • Fetal Development

Background:

  • Central hemodynamic abnormalities may precede impaired fetal growth.
  • Understanding cardiac output (CO) and total peripheral vascular resistance (TPVR) trajectories is crucial.

Purpose of the Study:

  • To assess cardiac output (CO) and total peripheral vascular resistance (TPVR) trajectories in singleton pregnancies with and without impaired fetal growth.
  • To conduct a systematic review and meta-analysis of existing studies.

Main Methods:

  • Systematic search of PubMed and Embase databases (inception - July 2023).
  • Inclusion of studies reporting CO and TPVR in pregnancies with impaired fetal growth, excluding those with pre-existing hypertension or cardiac disease.
  • Meta-analysis using a random-effects model to calculate absolute hemodynamic values and subgroup analyses for severe phenotypes.

Main Results:

  • Thirty-three studies involving 7816 women were analyzed.
  • No difference in non-pregnant hemodynamic function was observed between groups.
  • Impaired fetal growth was associated with elevated second and third-trimester TPVR and reduced third-trimester CO.
  • Higher TPVR was noted in more severe fetal growth restriction phenotypes.

Conclusions:

  • Impaired fetal growth is linked to increased vascular resistance and reduced CO starting in the second trimester.
  • More severe fetal growth restriction phenotypes exhibit a more vasoconstrictive hemodynamic profile.
  • Future research should explore preventive measures to normalize hemodynamic function.
Abstract

Related Concept Videos

Fetal Circulation01:14

Fetal Circulation

Fetal circulation is a unique system that facilitates the exchange of gases, nutrients, and waste products between the developing fetus and the mother. This intricate process takes place through a special organ called the placenta.
Two umbilical arteries transport blood from the fetus to the placenta. At the placenta, the blood absorbs oxygen and nutrients while simultaneously eliminating waste products. This oxygen-enriched and nutrient-rich blood then returns to the fetus through one...
2.4K
Mitral Valve Prolapse III: Nursing Management01:19

Mitral Valve Prolapse III: Nursing Management

The nursing management of Mitral Valve Prolapse, or MVP, centers around patient education, symptom monitoring, and lifestyle modifications.Patient Education on MVP Diagnosis and Heredity: Nurses should provide comprehensive education about MVP, a condition where the mitral valve does not close appropriately during heartbeats. This education often includes the condition's pathophysiology, symptoms, and potential complications, like arrhythmias or mitral regurgitation. Though not fully...
255
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
3.9K